L3VLUP
ProSign in

ARQT · LLY in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

ARQTLLY
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • ARQT
  • LLY
0204060202120222023202420252026
Holders and value by quarter
QuarterARQTLLY
Q3 2020none listed holders, n.a.33 holders, $14.1bn
Q4 20201 holders, $25m29 holders, $17.3bn
Q1 20211 holders, $13m24 holders, $23.0bn
Q2 20211 holders, $24m24 holders, $27.8bn
Q3 20211 holders, $48m31 holders, $29.9bn
Q4 20212 holders, $57m31 holders, $34.7bn
Q1 20222 holders, $34m24 holders, $35.3bn
Q2 20221 holders, $42m33 holders, $42.7bn
Q3 20223 holders, $86m31 holders, $43.4bn
Q4 20224 holders, $44m31 holders, $46.6bn
Q1 20234 holders, $57m33 holders, $44.3bn
Q2 20234 holders, $45m37 holders, $59.6bn
Q3 20233 holders, $13m44 holders, $67.6bn
Q4 2023none listed holders, n.a.45 holders, $73.6bn
Q1 20244 holders, $23m41 holders, $95.3bn
Q2 20245 holders, $15m43 holders, $110bn
Q3 20243 holders, $3.4m45 holders, $107bn
Q4 20244 holders, $30m46 holders, $93.9bn
Q1 20253 holders, $12m42 holders, $98.4bn
Q2 20255 holders, $63m43 holders, $93.2bn
Q3 20254 holders, $64m39 holders, $86.7bn
Q4 20254 holders, $85m41 holders, $123bn
Q1 20265 holders, $118m39 holders, $106bn
Q2 20263 holders, $112m44 holders, $132bn
ARQT

Arcutis Biotherapeutics Inc

Holders
5
Reported value
$118m
Buyers
11
Sellers
16

Breadth -5 among 91 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations
LLY

Eli Lilly & Co

Holders
39
Reported value
$106bn
Buyers
25
Sellers
25

Breadth 0 among 91 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q1 2026

Among the 41 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only ARQT (2)

Farallon Capital Management LLC, PDT Partners LLC

Only LLY (36)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, ARK Investment Management LLC, Arrowstreet Capital LP, Artisan Partners LP, Brevan Howard Capital Management LP, Bridgewater Associates LP, Capital Research Global Investors, Capital World Investors, Caxton Associates LLP, Citadel Advisors LLC, D. E. Shaw & Co., Dodge & Cox, ExodusPoint Capital Management LP, Fidelity (FMR LLC), GAMCO Investors Inc, Harris Associates LP, Holocene Advisors LP, Hudson Bay Capital Management LP, Invesco Ltd, Man Group PLC, Millennium Management LLC, Neuberger Berman Group LLC, Point72 Asset Management LP, and 11 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →